Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortalityIlenia Gatto, Caterina Bellinazzi, Marzia Scotti et al.|Intensive Care Medicine|2022Cited by 92
Two Fatal Cases of Acute Liver Failure Due to HSV-1 Infection in COVID-19 Patients Following Immunomodulatory TherapiesStefano Busani, Sara De Biasi, Andrea Bedini et al.|Clinical Infectious Diseases|2020Cited by 49
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unitMarianna Meschiari, Cristina Mussini, José-Marı́a López-Lozano et al.|Antimicrobial Resistance and Infection Control|2021Cited by 48
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediatorCristina Mussini, Domenico Lo Tartaro, Alessandro Cozzi‐Lepri et al.|Clinical Microbiology and Infection|2021Cited by 22
Intravenous fosfomycin in combination regimens as a treatment option for difficult-to-treat infections due to multi-drug-resistant Gram-negative organisms: A real-life experienceMarianna Meschiari, Cristina Mussini, Matteo Faltoni et al.|International Journal of Antimicrobial Agents|2024Cited by 18